Editorial Board for section 'Biomarkers'
- Inherited Heart Disease-Children Section
- Inherited Aortic Disease Section
- Rare Disease-Genetic Syndromes Section
- Rare Disease-Metabolic Diseases Section
- Rare Disease-Neuromuscular Diseases Section
- Molecular Genetics Section
- Biomarkers Section
- Cardiovascular Genetics in Clinical Practice Section
- Sport Cardiology Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Department of Internal Medicine-II, Paracelsus Medical University, 5020 Salzburg, Austria
Interests: heart failure; cardiovascular disease; chronic kidney disease; metabolic comorbidities; circulating biomarkers; extracellular vesicles; progenitor cells; multiple biomarker panel; prognosis
Special Issues, Collections and Topics in MDPI journals
Interests: heart failure; cardiovascular disease; chronic kidney disease; metabolic comorbidities; circulating biomarkers; extracellular vesicles; progenitor cells; multiple biomarker panel; prognosis
Special Issues, Collections and Topics in MDPI journals
1. School of Cardiovascular & Metabolic Health, University of Glasgow, Glasgow G12 8TA, UK
2. Department of Cardiology, Queen Elizabeth University Hospital, Glasgow G51 4TF, UK
Interests: inherited cardiac conditions; hypertrophic cardiomyopathy; biomarkers
2. Department of Cardiology, Queen Elizabeth University Hospital, Glasgow G51 4TF, UK
Interests: inherited cardiac conditions; hypertrophic cardiomyopathy; biomarkers
Marian Smoluchowski Institute of Physics, Jagiellonian University, Kraków, Poland
Interests: new biomarkers of onco- and vascular diseases, with the focus on endothelial dysfunction and proinflammatory mediators; microRNA and extracellular microvesicles as potential targets in therapy (cancer, diabetes); theranostics; nanomedicine
Interests: new biomarkers of onco- and vascular diseases, with the focus on endothelial dysfunction and proinflammatory mediators; microRNA and extracellular microvesicles as potential targets in therapy (cancer, diabetes); theranostics; nanomedicine
